SCHEMBL19612588

SCHEMBL19612588

O=C(Cc1ccc(OCc2ccccc2)cc1)N1CCOC1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FAAH O00519 7/20 1.00
NAAA Q02083 10/20 0.78
ALOX5 P09917 2/20 0.50
HRH3 Q9Y5N1 1/20 0.49
PARP10 Q53GL7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19612755 0.88 NAAA (1.00) FAAHNAAA
SCHEMBL16337701 0.87 NAAA (0.83) FAAHNAAA
SCHEMBL19612567 0.86 FAAH (1.00) FAAHNAAA
SCHEMBL19612619 0.84 NAAA (1.00) FAAHNAAA
SCHEMBL19612649 0.81 NAAA (1.00) FAAHNAAAHRH3
SCHEMBL11117435 0.80 MAPT (0.67) FAAH
SCHEMBL28522750 0.78 FAAH (0.64) FAAHNAAAHRH3
SCHEMBL19612661 0.78 FAAH (1.00) FAAHNAAA
SCHEMBL19612536 0.76 NAAA (1.00) FAAHNAAA
SCHEMBL13530140 0.75 FAAH (0.60) FAAHNAAAALOX5HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10174015-B2 Substituted heterocyclic derivative, preparation method and use thereof XIAMEN UNIVERSITY (CN) 2019-01-08 US disclosed
US-10174015-B2 Substituted heterocyclic derivative, preparation method and use thereof XIAMEN UNIVERSITY (CN) 2019-01-08 US disclosed
US-20170334896-A1 Substituted Heterocyclic Derivative, Preparation Method And Use Thereof XIAMEN UNIVERSITY (CN) 2017-11-23 US disclosed
US-20170334896-A1 Substituted Heterocyclic Derivative, Preparation Method And Use Thereof XIAMEN UNIVERSITY (CN) 2017-11-23 US disclosed
US-20170334896-A1 Substituted Heterocyclic Derivative, Preparation Method And Use Thereof XIAMEN UNIVERSITY (CN) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334896-A1 Substituted Heterocyclic Derivative, Preparation Method And Use Thereof FAAH, NAAA, FAAH2 FAAH 1/4885NAAA 2/4885ALOX5 502/4885
US-10174015-B2 Substituted heterocyclic derivative, preparation method and use thereof DHPS, CYP3A5, CYP3A4 FAAH 934/4885NAAA 557/4885ALOX5 1034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.